Antiseptic properties of the solution generated by the IOON MED device

Authors

  • Mykhailo Manuilov I. Mechnikov Institute of microbiology and immunology of NAMSU, Ukraine
  • Artur Martynov I.Mechnikov institute of microbiology and immunology of AMSU, Ukraine https://orcid.org/0000-0003-1428-0085
  • Andriy Manuilov Andriy Manuilov, sole proprietor, Ukraine
  • Nadiia Skliar I.Mechnikov institute of microbiology and immunology of NAMSU, Ukraine
  • Olena Batrak I.Mechnikov institute of microbiology and immunology of NAMSU, Ukraine

DOI:

https://doi.org/10.5281/zenodo.11638191

Keywords:

Antiseptic, electrochemical, antimicrobial, titer, peritonitis model in mice, atomic hydrogen, active chlorine

Abstract

Introduction. The spread of antibiotic- and antiseptic-resistant hospital-acquired infections is a highly relevant problem both in Ukraine and in other countries, even those with developed and modern healthcare systems. For example, cases of the spread of nosocomial strains in the United States , the European Union , Canada, the United Kingdom, Japan, etc. have been described.  The World Health Organization describes the problem of the spread of nosocomial strains as global and one that needs to be addressed as soon as possible.  In Ukraine, additional negative factors contributing to the spread of nosocomial infections include - a significant increase in the burden on health care facilities, especially military ones, due to a significant number of patients with gunshot wounds and mine-blast injuries sustained as a result of the armed aggression of the rf . Gunshot wounds and mine-blast traumas are considered infected by default; - shortage of medical personnel in healthcare facilities in Ukraine; - widespread self-medication among the population, including with antibiotics, which results in pathogens gaining resistance to a wide range of antibiotic drugs. Materials and methods. Method of antiseptic treatment of infected Petri dishes.  An 18-24 hour culture of microorganisms was used. Muller-Hinton agar was used for bacteria. Sabouraud agar was used for Candida albicans. The bacterial suspension was applied to a sterile Petri dish, the suspension was evenly distributed over the surface, and the Petri dish was placed in a sterile microbiological box for 20-25 minutes until the suspension was completely dry. After the suspension was completely dry, the infected surface of the Petri dish was treated with the IOON MED device.  To establish the safety of the antiseptic synthesized by the IOON MED device, as well as to determine its effectiveness in vivo, a study was conducted on white laboratory mice.  For the study, 30 healthy, young, linear white mice of both sexes were selected. The animals were divided into 3 groups of 10 animals each, each group was isolated in a cage, separately from the main population and other groups. The study was conducted to model purulent peritonitis in experimental animals according to FDA recommendations. Animals in experimental group were injected with a lethal (LD100) dose of Pseudomonas aeruginosa intraperitoneally and 4 hours after the administration of the bacterial suspension, 1 ml of freshly synthesized IOON MED antiseptic at the maximum titer was injected and the animals were monitored for 24 hours, after which mortality in the group was recorded. Results and discussion. In fact, the antiseptic generated by the IOON MED device exhibits properties similar to the control products on the market. All antiseptic solutions generated by devices 1-5 showed antimicrobial activity against S. aureus - no staphylococcal growth was observed on the Petri dishes, while the control showed classic bacterial growth. On Petri dishes treated with test solutions from the IOON MED device (1-5), the growth of single colonies is observed, just as in the control groups, where Petri dishes with microorganisms were treated with hydrogen peroxide and chlorhexidine. The control hydrogen peroxide did not actually affect the biofilm and did not differ from the control, while chlorhexidine, similarly to the IOON MED solution samples, caused the death of all microorganisms in the biofilms. Thus, test groups 1-5 are statistically significantly different from the control group in terms of the degree of antimicrobial effect, while no statistical differences were observed from the effect of chlorhexidine. For samples 2, 3, 5, the titer of antimicrobial action was 1:64. For sample 4, the titer was 1:128. Thus, it can be reliably stated that the average titer of activity of the antiseptic solution generated by IOON MED based on the results of a twofold dilution of the solution is at least 1:64. In the group of mice that were injected with 1 ml of IOON MED antiseptic solution 3 hours after infection, 6 animals died, while in the control group of untreated mice all 10 animals died. The difference in the groups is statistically significant. Conclusion. The solution generated by the electrochemical device IOON MED is able to kill bacteria inside the biofilm formed on a fragment of the endotracheal tube by the multidrug-resistant strain Acinetobacter baumannii 718. Of the controls, only chlorhexidine showed antiseptic properties against bacteria inside biofilms. There is no statistical difference between the effectiveness of chlorhexidine and the test solutions 1-5. For the solutions generated by the electrochemical device IOON MED, titers were established - the maximum twofold dilutions that showed antiseptic properties. The average titer was 1:64, for individual samples 1:128 for multidrug-resistant S. aureus.  The antiseptic solution generated by the IOON MED device showed statistically significant therapeutic antimicrobial activity in a model of purulent peritonitis in mice.

Keywords. Antiseptic, electrochemical, antimicrobial, titer, peritonitis model in mice, atomic hydrogen, active chlorine

References

Salmanov A, Vdovychenko YP, Nychytailo MY, Andriuschenko D, Verner O. Incidence of Surgical Site Infections (SSIs) and Antimicrobial Resistance their Pathogens in Ukraine. International Journal of Antiibiotics and Probiotics 2018:18–29. https://doi.org/10.31405/ijap.2-1.18.02.

Avershina E, Shapovalova V, Shipulin G. Fighting antibiotic resistance in hospital-acquired infections: current state and emerging technologies in disease prevention, diagnostics and therapy. Frontiers in Microbiology 2021;12:707330. https://doi.org/10.3389/fmicb.2021.707330.

Ricard J-D, Conti G, Boucherie M, Hormann C, Poelaert J, Quintel M, et al. A European survey of nosocomial infection control and hospital-acquired pneumonia prevention practices. Journal of Infection 2012;65:285–91. https://doi.org/10.1016/j.jinf.2012.06.016.

Abban MK, Ayerakwa EA, Mosi L, Isawumi A. The burden of hospital acquired infections and antimicrobial resistance. Heliyon 2023. https://doi.org/10.1016/j.heliyon.2023.e20561.

Nguyen M, Joshi S. Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital-acquired infections: a scientific review. Journal of Applied Microbiology 2021;131:2715–38. https://doi.org/10.1111/jam.15130.

Lompo P, Heroes A-S, Agbobli E, Kühne V, Tinto H, Affolabi D, et al. Bacterial Contamination of Antiseptics, Disinfectants and Hand Hygiene Products in Healthcare Facilities in High-Income Countries: A Scoping Review. Hygiene 2023;3:136–75.

Afzal S, Junaid K, Aziz F. A Hospital-Acquired Infection: A Public Health Problem. Annals of King Edward Medical University 2021;27.

Petrosillo N, Petersen E, Antoniak S. Ukraine war and antimicrobial resistance. The Lancet Infectious Diseases 2023;23:653–4. https://doi.org/10.1016/S1473-3099(23)00264-5.

Bespalova O, Bugayenko T, Mezentseva I, Savchuk I, Kirilyuk V. Epidemiology of combat injuries of servicemen during the armed conflict. Prospects and Innovations of Science 2024.

Uwishema O, Sujanamulk B, Abbass M, Fawaz R, Javed A, Aboudib K, et al. Russia-Ukraine conflict and COVID-19: a double burden for Ukraine’s healthcare system and a concern for global citizens. Postgraduate Medical Journal 2022;98:569–71.

Babbar R, Arora R, Kaur R, Babu MA, Rana P, Dhiman S, et al. Antibiotic Drug Resistance and Covid 19: Challenges and Future Perspectives. Korean Journal of Physiology and Pharmacology 2023;27:82–9.

Salmanov A, Shchehlov D, Artyomenko V, Svyrydiuk O, Maliarchuk R, Bortnik I, et al. Nosocomial transmission of multi-drug-resistant organisms in Ukrainian hospitals: results of a multi-centre study (2019–2021). Journal of Hospital Infection 2023;132:104–15. https://doi.org/10.1016/j.jhin.2022.12.008.

Lemiech-Mirowska E, Kiersnowska ZM, Michałkiewicz M, Depta A, Marczak M. Nosocomial infections as one of the most important problems of healthcare system. Annals of Agricultural and Environmental Medicine 2021;28. https://doi.org/10.26444/aaem/122629.

Maslov O, Kolisnyk S, Komisarenko M, Komisarenko A, Osolodchenko T, Ponomarenko S. In vitro antioxidant and antibacterial activities of green tea leaves (Camella sinensis l.) liquid extracts. Annals of Mechnikov’s Institute 2022:64–7.

Koller M. Production, properties, and processing of microbial polyhydroxyalkanoate (PHA) biopolyesters. Microbial and Natural Macromolecules, Elsevier; 2021, p. 3–55.

Trofimenko Y, Zhorniak O, Fomina N, Burkot V, Kulik A, Zhorniak P. Study of the effectiveness of using decamethoxin-based antiseptic compositions for treating endotracheal tubes in order to prevent the development of ventilator-associated pneumonia in intensive care patients. Reports of Vinnytsia National Medical University 2020;24:17–9. https://doi.org/10.31393/reports-vnmedical-2020-24(1)-03.

Urgancı NN, Yılmaz N, Alaşalvar GK, Yıldırım Z. Pseudomonas aeruginosa and its pathogenicity. Turkish Journal of Agriculture-Food Science and Technology 2022;10:726–38. https://doi.org/10.24925/turjaf.v10i4.726-738.4986.

Karnwal A, Kumar G, Pant G, Hossain K, Ahmad A, Alshammari MB. Perspectives on usage of functional nanomaterials in antimicrobial therapy for antibiotic-resistant bacterial infections. ACS Omega 2023;8:13492–508. https://doi.org/10.1021/acsomega.3c00110.

Turhan NS. Karl Pearson’s Chi-Square Tests. Educational Research and Reviews 2020;16:575–80.

Published

2024-06-15

How to Cite

Manuilov, M. ., Martynov, A., Manuilov, A., Skliar, N. ., & Batrak, O. . (2024). Antiseptic properties of the solution generated by the IOON MED device. Annals of Mechnikov’s Institute, (2), 74–81. https://doi.org/10.5281/zenodo.11638191

Issue

Section

Research Articles